首页> 美国卫生研究院文献>Ethiopian Journal of Health Sciences >Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative Bleeding
【2h】

Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative Bleeding

机译:Epsilon氨基己酸和氨甲环酸在体外循环手术中的术中使用:一项比较研究评估其对术后出血引起的再开放的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundOpen heart surgeries under cardiopulmonary bypass are associated with excessive perioperative bleeding that often requires reoperation. Antifibrinolytics like epsilon aminocaproic acid and tranexamic acid are widely used to control bleeding. There are limited studies primarily showing the impact of these drugs on the incidence of reopening following open heart surgical procedures. The goal of this study was to compare incidence of reopening following open heart surgeries in patients who were administered either epsilon amino caproic acid or tranexamic acid for control of perioperative bleeding.
机译:背景技术在体外循环下进行开放式心脏手术会导致围手术期出血过多,常常需要再次手术。诸如ε氨基己酸和氨甲环酸等抗纤维蛋白溶解剂被广泛用于控制出血。有限的研究主要显示这些药物对心脏直视手术后再次开放发生率的影响。这项研究的目的是比较接受ε-氨基己酸或氨甲环酸控制围手术期出血的患者,在进行心脏直视手术后再次开放的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号